|
Volumn 78, Issue 3, 2007, Pages 405-411
|
Recombinant human epidermal growth factor (REGEN-D™ 150): Effect on healing of diabetic foot ulcers
|
Author keywords
Diabetic foot ulcers; EGF; Epidermal growth factor; PMS study; REGEN D 150
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
ANTIBIOTIC AGENT;
CEPHALOSPORIN;
CLINDAMYCIN;
FUSIDATE SODIUM;
GAMMA UROGASTRONE;
GLIPIZIDE;
INSULIN;
LINEZOLID;
MEROPENEM;
METFORMIN;
METRONIDAZOLE;
ORAL ANTIDIABETIC AGENT;
POVIDONE IODINE;
PSEUDOMONIC ACID;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RECOMBINANT EPIDERMAL GROWTH FACTOR;
REGEN D;
SULFONYLUREA;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETIC FOOT;
DRUG EFFECT;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
MAJOR CLINICAL STUDY;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PHASE 4 CLINICAL TRIAL;
POSTMARKETING SURVEILLANCE;
WOUND CLOSURE;
WOUND HEALING;
WOUND INFECTION;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
CHILD;
CLINICAL TRIALS, PHASE II AS TOPIC;
DIABETIC FOOT;
EPIDERMAL GROWTH FACTOR;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
PATIENT SELECTION;
RECOMBINANT PROTEINS;
RETROSPECTIVE STUDIES;
WOUND HEALING;
|
EID: 35748972337
PISSN: 01688227
EISSN: None
Source Type: Journal
DOI: 10.1016/j.diabres.2007.06.004 Document Type: Article |
Times cited : (56)
|
References (9)
|